Erectile dysfunction (impotence) is the inability to get and keep an erection firm enough for sexual intercourse. Erectile dysfunction symptoms might include persistent: trouble getting an erection, trouble keeping an erection, or reduced sexual desire.
Hormones are chemical messengers that influence cellular activity and impact every function of the body and chronic diseases such as heart disease, stroke, cancer, type 2 diabetes, obesity, arthritis, chronic kidney, liver disease, and chronic obstructive lung disease lead to erectile dysfunction as these diseases affect blood vessels, nerves, and hormone levels in the body. Erectile dysfunction (ED) is a common condition among male chronic kidney disease (CKD) patients. Its prevalence is estimated to be approximately 80% among these patients according to World Journal of Nephrology in 2014.
Global Erectile Dysfunction Devices Market - Impact of the Coronavirus (COVID-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 215.7 million cases and 4.49 million deaths due to coronavirus (COVID-19) were reported till August 29, 2021, across the globe.
Impact of COVID-19 on Demand and Supply of Erectile Dysfunction Devices:
Researchers have been investigating the potential onset of erectile dysfunction in male patients of COVID-19. The researchers have stated three factors which can lead to the potential onset of erectile dysfunction (ED) in men who have suffered from COVID-19.
The global erectile dysfunction devices market is estimated to be valued at US$ 1,303.8 Mn in 2021, and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028).
Figure 1: Global Erectile Dysfunction Devices Market Share (%) Analysis, By Device Type, 2021
Increasing prevalence of erectile dysfunction due to chronic diseases and aging is the major factor that is expected to drive the market growth over the forecast period.
Increasing prevalence of erectile dysfunction due to various chronic diseases and aging of the global population, is expected to increase the growth of the global erectile dysfunction devices market over the forecast period. For instance, according to the article published by the Center for Disease Control and Prevention (CDC), in 2018, 51.8% of the U.S. adults had at least one chronic disease and 27.2% had multiple chronic diseases.
Furthermore, according to an article published in the Cleveland Clinic Center for Continuing Education in June 2018, around 17,781 new cases of erectile dysfunction are diagnosed in Massachusetts, U.S. every year, while approximately 617,715 new cases of erectile dysfunction are reported in the U.S. annually.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2020 | Market Size in 2021: | US$ 1,303.8 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2021 to 2028 |
| Forecast Period 2021 to 2028 CAGR: | 9.5% | 2028 Value Projection: | US$ 2,467.5 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Growing Adoption of Smoking and Alcoholism
For instance, according to the International Journal of Impotence Research: 2018, the use of tobacco has been considered as the major health problem worldwide, and the studies show that smoking causes erectile dysfunction among male population. Smoking can damage every part of the body and the chemicals present in cigarette smoke injure the lining of the blood vessels and can also affect the way they function. The chemicals present in the cigarette affects the blood vessels in the penis and, in turn, hampers erectile health. Even if the nervous system is operating at full strength, an erection may not be physically possible if the blood vessels are unhealthy due to smoking.
Furthermore, according to the JAMA Internal Medicine Journal: 2018, alcohol is regarded as a risk factor for erectile dysfunction (ED). Moreover, alcohol intake leads to increase in level of alcohol in blood. Alcohol being a depressant, can dampen the mood and decrease the sexual desire, which may cause difficultly for a person to achieve erections. For instance, according to the National Institute on Alcohol Abuse and Alcoholism: 2019, about 14.5 million people in the U.S., in the age group of 12 and older, have alcohol use disorder (AUD). This number includes 9.0 million men (6.8% of men in this age group) and 5.5 million women (3.9% of women in this age group).
Global Erectile Dysfunction Devices Market – Restraints
The presence of alternative medicines and herbal remedies for the treatment of erectile dysfunction is expected to hamper the growth of the global erectile dysfunction devices market over the forecast period. For instance, according to the Arab Journal of Urology: February 03, 2021, complementary and alternative medicines, including dietary supplements and herbal remedies, are increasingly used for the treatment of erectile dysfunction, particularly through over-the-counter and internet sources. Examples include herbal medicines (remedies) and dietary supplements, nutritional and lifestyle therapies, acupuncture and traditional Chinese medicine, body therapies (such as massage, cupping, and acupressure), homeopathy, mind–body techniques (such as meditation and yoga), energy medicine (such as reiki), and other traditional medicine disciplines such as Ayurveda, Unani, and Naturopathy.
Global Erectile Dysfunction Devices Market – Regional Analysis
On the basis of region, the global erectile dysfunction devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global erectile dysfunction devices market over the forecast period, owing to increasing number of launching new erectile dysfunction devices. For instance, in July 2019, Boston Scientific Corporation, a manufacturer of medical devices, launched the Tactra implant, which is a durable implant with a natural feel for treating erectile dysfunction.
Figure 2: Global Erectile Dysfunction Devices Market Value (US$ Mn), by Region, 2021
Global Erectile Dysfunction Devices Market – Competitive Landscape
Major players operating in the global erectile dysfunction devices market include Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed
Patients suffering from erectile dysfunction initially opt for non-surgical treatment options such as oral phosphodiesterase type-5 inhibitors (Viagra, Cialis, and others), injections, injections, suppositories, and penis pumps. However, if a patient fails to respond for all the above mentioned treatment then penile implant has found to be the most common option for men seeking treatment for erectile dysfunction. For instance, according to the Cleveland Clinic, a non-profit academic medical center based in Ohio, U.S., around 20,000 American men opt for a penis implant every year. Penile implants are becoming widely accepted treatment option in the U.S. which is anticipated to boost the market growth over the forecast period. Furthermore, according to the study published in the Translational Andrology and Urology in February 2020, around 85.9% of total 63,013 total penile implantation procedures were performed in the U.S. from 2005 to 2012.
Market Dynamics
The rising prevalence of erectile dysfunction mandates the need to launch various awareness campaigns to focus on the treatment of this condition. Several manufacturers such as Pfizer are focusing on launching campaigns regarding erectile dysfunction. Some noteworthy examples are European impotence awareness campaign and unbranded erectile dysfunction awareness campaign aiming at younger men. For instance, in the U.S., February 14 is considered as a National Impotence Day, where the government and healthcare workers create awareness about erectile dysfunction, its causes, and the available treatment options for erectile dysfunction. Moreover, they also focus on the types of erectile dysfunction and how it affects the mental health.
Furthermore, several market players commercialize various technologically advanced non-invasive devices for the treatment of erectile dysfunction, which is expected to boost the market growth over the forecast period. For instance, Vertica is a non-invasive home use medical device designed to enhance erectile quality, which is manufactured by OHH-MED Medical Ltd., a medical device company.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients